We are live on ! Find out more
AIM

Allen Investment Management Portfolio holdings

AUM $8.43B
1-Year Est. Return 20.31%
This Fund
S&P 500
This Quarter Est. Return
+7.54%
1 Year Est. Return
+20.31%
3 Year Est. Return
+92.36%
5 Year Est. Return
+101.99%
10 Year Est. Return
+554.07%
AUM
$1.37B
AUM Growth
+$41.5M
Cap. Flow
-$9.05M
Cap. Flow %
-0.66%
Top 10 Hldgs %
33.23%
Holding
258
New
33
Increased
62
Reduced
69
Closed
29

Top Buys

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$44M
2
DTV
DIRECTV COM STK (DE)
DTV
+$32.4M
3
DHR icon
Danaher
DHR
+$25.8M
4
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$20.5M
5
PCYC
PHARMACYCLICS INC
PCYC
+$19.3M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$86.9M
2
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$61.4M
3
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$45M
4
TLM
TALISMAN ENERGY INC
TLM
+$19.6M
5
SXC icon
SunCoke Energy
SXC
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 21.45%
2 Technology 16.55%
3 Industrials 7.98%
4 Consumer Discretionary 7.23%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
151
Incyte
INCY
$24.6B
$475K 0.03%
5,183
– –
ETFC
152
DELISTED
E*Trade Financial Corporation
ETFC
$475K 0.03%
+16,635
New +$424K
SYNA icon
153
Synaptics
SYNA
$4.09B
$458K 0.03%
5,637
– –
QEP
154
DELISTED
QEP RESOURCES, INC.
QEP
$456K 0.03%
21,891
-3,394
-13% -$70.9K
DATA
155
DELISTED
Tableau Software, Inc.
DATA
$454K 0.03%
4,910
– –
LNKD
156
DELISTED
LinkedIn Corporation
LNKD
$454K 0.03%
1,816
– –
IONS icon
157
Ionis Pharmaceuticals
IONS
$9.46B
$453K 0.03%
7,114
– –
PFN
158
PIMCO Income Strategy Fund II
PFN
$707M
$445K 0.03%
44,300
-4,999
-10% -$50.8K
STIP icon
159
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$444K 0.03%
4,470
– –
JPC icon
160
Nuveen Preferred & Income Opportunities Fund
JPC
$2.93B
$440K 0.03%
46,221
-5,194
-10% -$49.5K
TYL icon
161
Tyler Technologies
TYL
$13B
$437K 0.03%
3,625
– –
PPO
162
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$425K 0.03%
7,208
– –
FMX icon
163
Fomento Económico Mexicano
FMX
$40.9B
$421K 0.03%
4,500
– –
GS icon
164
Goldman Sachs
GS
$301B
$413K 0.03%
+2,199
New +$409K
MANH icon
165
Manhattan Associates
MANH
$11.4B
$413K 0.03%
+8,159
New +$393K
INTC icon
166
Intel
INTC
$492B
$407K 0.03%
13,017
-503
-4% -$17K
NE
167
DELISTED
Noble Corporation
NE
$407K 0.03%
28,469
-192
-0.7% -$3.12K
SNDK
168
DELISTED
SANDISK CORP
SNDK
$407K 0.03%
6,400
+1,448
+29% +$118K
EIM
169
Eaton Vance Municipal Bond Fund
EIM
$499M
$399K 0.03%
30,904
-3,579
-10% -$46.2K
NFLX icon
170
Netflix
NFLX
$318B
$399K 0.03%
66,990
– –
NIO
171
DELISTED
NUVEEN MUNICIPAL OPPORTUNITY FUND INC
NIO
$397K 0.03%
27,077
-2,706
-9% -$39.4K
LM
172
DELISTED
Legg Mason, Inc.
LM
$392K 0.03%
7,095
-1,007
-12% -$56.5K
DAR icon
173
Darling Ingredients
DAR
$9.91B
$384K 0.03%
27,433
+6,800
+33% +$112K
CRI icon
174
Carter's
CRI
$1.48B
$376K 0.03%
+4,066
New +$351K
ABT icon
175
Abbott
ABT
$188B
$373K 0.03%
8,060
– –
5 6
7
8 9

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return

Allen Investment Management's Q1 2015 Portfolio in Review

As of Q1 2015, Allen Investment Management held 258 positions worth $1.37B, up 3.1% from $1.32B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Allen Investment Management's Q1 2015 filing shows 33 new, 62 increased, 69 reduced and 29 closed positions. Its largest new stake was SALIX PHARMACEUTICALS LTD DEL: 300,000 shares worth $51.8M. The largest sale was Allergan Inc, an estimated $86.9M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 29% a quarter earlier, followed by Technology and Industrials.

  • Allen Investment Management's largest Q1 2015 buy was SALIX PHARMACEUTICALS LTD DEL: 300,000 shares worth $51.8M.
  • Allen Investment Management added most to DIRECTV COM STK (DE) in Q1 2015, an estimated $32.4M increase.
  • Allen Investment Management's biggest Q1 2015 reduction was Molson Coors Class B, cutting an estimated $16M.
  • Allen Investment Management fully exited Allergan Inc in Q1 2015, selling an estimated $86.9M.
  • Allen Investment Management's ten largest holdings make up 33% of its $1.37B portfolio in Q1 2015.
  • Allen Investment Management opened 33 new positions and closed 29 in Q1 2015.
  • Allen Investment Management's portfolio value rose 3.1% quarter-over-quarter to $1.37B.

Based on Allen Investment Management's 13F filing for Q1 2015, filed 15 May 2015.